AbbVie Inc. — Director's Dealing 2013

Sep 18, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-09-16

Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-16	Common stock, $0.01 par value	M	4100	$27.294	Acquired	68379	Direct
2013-09-16	Common stock, $0.01 par value	M	2200	$28.3225	Acquired	70579	Direct
2013-09-16	Common stock, $0.01 par value	S	4989	$45.50	Disposed	65590	Direct
2013-09-17	Common stock, $0.01 par value	M	4600	$28.8628	Acquired	70190	Direct
2013-09-17	Common stock, $0.01 par value	M	1997	$37.18	Acquired	72187	Direct
2013-09-17	Common stock, $0.01 par value	S	3695	$46.00	Disposed	68492	Direct
2013-09-17	Common stock, $0.01 par value	S	1789	$46.48	Disposed	66703	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-16	Option (right to buy)	$27.294	M	4100	Disposed	2017-02-15	Common stock (4100)	Direct
2013-09-16	Option (right to buy)	$28.3225	M	2200	Disposed	2018-03-30	Common stock (2200)	Direct
2013-09-17	Option (right to buy)	$28.8628	M	4600	Disposed	2018-02-14	Common stock (4600)	Direct
2013-09-17	Option (right to buy)	$37.18	M	1997	Disposed	2014-02-19	Common stock (1997)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	1673	Indirect
Common stock, $0.01 par value	110	Indirect

Footnotes

F1: Balance in the AbbVie Savings Program as of September 17, 2013.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.